These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 28506536

  • 21. [Not Available].
    Mateus C, Libenciuc C, Robert C.
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S4-S11. PubMed ID: 27494973
    [Abstract] [Full Text] [Related]

  • 22. Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab.
    Muto Y, Kitano S, Tsutsumida A, Namikawa K, Takahashi A, Nakamura Y, Yamanaka T, Yamamoto N, Yamazaki N.
    J Dermatol; 2019 Jun; 46(6):498-506. PubMed ID: 30945333
    [Abstract] [Full Text] [Related]

  • 23. Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
    Ellis PM, Vella ET, Ung YC.
    Clin Lung Cancer; 2017 Sep; 18(5):444-459.e1. PubMed ID: 28416123
    [Abstract] [Full Text] [Related]

  • 24. Two Cases of Sinusitis Induced by Immune Checkpoint Inhibition.
    Dein E, Sharfman W, Kim J, Gellad F, Shah AA, Bingham CO, Cappelli LC.
    J Immunother; 2017 Oct; 40(8):312-314. PubMed ID: 28614096
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ipilimumab Combined with Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
    Carlino MS, Long GV.
    Clin Cancer Res; 2016 Aug 15; 22(16):3992-8. PubMed ID: 27340279
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.
    Hodi FS, Chesney J, Pavlick AC, Robert C, Grossmann KF, McDermott DF, Linette GP, Meyer N, Giguere JK, Agarwala SS, Shaheen M, Ernstoff MS, Minor DR, Salama AK, Taylor MH, Ott PA, Horak C, Gagnier P, Jiang J, Wolchok JD, Postow MA.
    Lancet Oncol; 2016 Nov 15; 17(11):1558-1568. PubMed ID: 27622997
    [Abstract] [Full Text] [Related]

  • 33. Pembrolizumab use for the treatment of advanced melanoma.
    Specenier P.
    Expert Opin Biol Ther; 2017 Jun 15; 17(6):765-780. PubMed ID: 28323504
    [Abstract] [Full Text] [Related]

  • 34. Pembrolizumab versus Ipilimumab in Advanced Melanoma.
    Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank CU, Hamid O, Mateus C, Shapira-Frommer R, Kosh M, Zhou H, Ibrahim N, Ebbinghaus S, Ribas A, KEYNOTE-006 investigators.
    N Engl J Med; 2015 Jun 25; 372(26):2521-32. PubMed ID: 25891173
    [Abstract] [Full Text] [Related]

  • 35. Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma.
    Changizzadeh PN, Mukkamalla SKR, Armenio VA.
    J Immunother Cancer; 2017 Dec 19; 5(1):97. PubMed ID: 29254501
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety data for checkpoint inhibitors in advanced melanoma under real-life conditions: A monocentric study conducted in Nice from 2010 to 2016.
    Taquin H, Fontas E, Massol O, Chevallier P, Balloti R, Beranger G, Lacour JP, Passeron T, Montaudié H.
    Ann Dermatol Venereol; 2018 Nov 19; 145(11):649-658. PubMed ID: 30098818
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors.
    Firwana B, Ravilla R, Raval M, Hutchins L, Mahmoud F.
    J Oncol Pharm Pract; 2017 Dec 19; 23(8):620-624. PubMed ID: 27590328
    [Abstract] [Full Text] [Related]

  • 40. One or Two Immune Checkpoint Inhibitors?
    Robert C, Lanoy E, Besse B.
    Cancer Cell; 2019 Dec 09; 36(6):579-581. PubMed ID: 31951559
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.